Peakdale Molecular (part of the Concept Life Sciences Group) offers its customers a ﬁrst class range of extensive integrated medicinal chemistry services for drug discovery. These services build on the company’s core strengths of highly innovative and world-renowned chemistry, its reputation for delivering quality products to customers on time and its passion for synthetic organic chemistry when applied to biological problems. Peakdale has built up medicinal chemistry and computer chemistry expertise across therapeutic areas, spanning the drug discovery process from hit generation to Phase I clinical studies. Peakdale has a proven track record of success in producing robust candidates suitable for proof-of-concept testing in vivo. To achieve this, the Company utilises its highly experienced and committed teams to deliver on project goals and ensure complete client confidentiality and protection of Intellectual Property (IP). Peakdale is able to contribute fully to the early drug discovery process with the capability to use its compound collection or custom designed sets of compounds to generate a hit, medicinal chemistry optimisation capabilities and scale up facilities to aid a customer in an efficient research programme to achieve their biological proof of concept end point.
Specialties Medicinal Chemistry, Synthetic Organic Chemistry, ADMET, Custom Synthesis, Contract Research (FTE), Computational Chemistry, Analytical Chemistry, Microwave Chemistry, Nucleoside and Nucleotide Chemistry, Organic Electronics, Hydrogenation, Pressure Chemistry